Anhui's first high-growth industrial bond was successfully issued in Shanghai. Recently, Anhui Wantong Expressway Co., Ltd. (referred to as "Wantong Expressway") completed the issuance of Anhui's first high-growth industrial bond in Shanghai Stock Exchange. On October 30th this year, Wan Tong Expressway was approved by China Securities Regulatory Commission to publicly issue corporate bonds with a registered scale of no more than 5 billion yuan to professional investors.The turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 584.4 billion yuan, that of Shenzhen Stock Exchange was 899.8 billion yuan, and that of Beizheng 50 was 15.8 billion yuan.Zhongzhiwei Technology completed tens of millions of yuan financing. On December 12th, Nanjing Zhongzhiwei Information Technology Co., Ltd. (Zhongzhiwei Technology) completed tens of millions of yuan B1 financing, which was jointly invested by Guangzhou Baiyun Financial Holding Group Co., Ltd. and Beijing Hongfeng Private Equity Fund Management Co., Ltd. This round of financing funds will be used for iterative application of AI+ network security products, breakthrough in key industry landing scenarios and market channel construction. Zhongzhiwei Technology is a solution provider of "city-level data+digital security operation", and has launched a series of new platform-based network security products around AISecOps (artificial intelligence security operation).
The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Guoxuan Hi-Tech: It plans to invest a total of 2.514 billion euros to build new energy battery production bases in Slovakia and Morocco. Guoxuan Hi-Tech announced that the company plans to invest in Slovakia with its own and self-raised funds to build high-performance lithium batteries and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.234 billion euros. On the same day, it was announced that the company plans to invest in Morocco with its own and self-raised funds to build a high-performance lithium battery and supporting projects with an annual output of 20GWh, with a total investment of no more than 1.28 billion euros.Russian central bank: Russia's current account surplus in November was $3.2 billion.
ECB: The appropriate monetary policy stance will be determined by data dependence and successive meetings. Inflation prospect, core inflation and its transmission will determine the interest rate path.South Korea's National Election Commission: Security vulnerabilities were discovered before, but most of them were fixed before the election. There is no evidence that North Korea hacked.Tang Lin, a former director-level cadre of the Higher People's Court of Guizhou Province, held a trial in the first instance. On December 12, 2024, the Intermediate People's Court of tongren city, Guizhou Province held a trial in the first instance to hear the case of Tang Lin, a former director-level cadre of the Higher People's Court of Guizhou Province. Tongren city People's Procuratorate prosecuted the charges: During 2012-2023, defendant Tang Lin took advantage of his position as President of Liupanshui Intermediate People's Court, Vice President of Guizhou Higher People's Court, Director of Legal Affairs Office of Guizhou Provincial People's Government, Executive Vice President of Guizhou Higher People's Court, and the convenience of his authority and position to help relevant units and individuals in handling cases, and illegally accepted other people's property totaling RMB 21.47 million. From December 2007 to January 2011, Tang Lin took advantage of his position as the president of Liupanshui Intermediate People's Court to facilitate the illegal possession of public property with others, totaling RMB 660,000, of which RMB 330,000 was shared by individuals. The public prosecution agency requested Tang Lin to be investigated for criminal responsibility for accepting bribes and corruption. (Dynamic and static Guizhou)
Strategy guide
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13